BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system

Press/Media

Period	25 Jan 2023

Media coverage

Title	BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system
Media name/outlet	Cardiovascular News
Country/Territory	United Kingdom
Date	25/01/23
URL	ct.moreover.com/?a=49840576487&p=1gw&v=1&x=8sAWYiHPxAVjtCx2Punyww
Persons	Gregg Stone